Serdar Dursun

An atypical long-acting injectable antipsychotic: implications for pharmacotherapy of schizophrenia
J Psychopharmacol 2005 19: 3-4. [PDF] [References]  

E. Parellada, R. Andrezina, V. Milanova, P. Glue, M. Masiak, M. St. John Turner, R. Medori, and W. Gaebel

Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable
J Psychopharmacol 2005 19: 5-14. [Abstract] [PDF] [References]  

W. Kissling, S. Heres, K. Lloyd, E. Sacchetti, P. Bouhours, R. Medori, and P. M. Llorca

Direct transition to long-acting risperidone - analysis of long-term efficacy
J Psychopharmacol 2005 19: 15-21. [Abstract] [PDF] [References]  

A. Mohl, K. Westlye, S. Opjordsmoen, A. Lex, A. Schreiner, M. Benoit, P. Bräunig, and R. Medori

Long-acting risperidone in stable patients with schizoaffective disorder
J Psychopharmacol 2005 19: 22-31. [Abstract] [PDF] [References]  

M. Gastpar, M. Masiak, M. A. Latif, S. Frazzingaro, R. Medori, and E. -R. Lombertie

Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine
J Psychopharmacol 2005 19: 32-38. [Abstract] [PDF] [References]  

Acknowledgements
J Psychopharmacol 2005 19: 39-40. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.